- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/82 - Benzo [b] furansHydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 307/82
Total number of patents in this class: 225
10-year publication summary
|
18
|
17
|
26
|
16
|
17
|
13
|
8
|
10
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2349 |
20 |
| The Johns Hopkins University | 5667 |
9 |
| Cardioxyl Pharmaceuticals, Inc. | 49 |
8 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 163 |
6 |
| The University of Queensland | 660 |
6 |
| Sanofi | 4055 |
6 |
| BASF SE | 20933 |
5 |
| Merck Sharp & Dohme Corp. | 2194 |
4 |
| Janssen Pharmaceutica N.V. | 3392 |
4 |
| Merck Patent GmbH | 5831 |
4 |
| Takeda Pharmaceutical Company Limited | 2713 |
4 |
| Bionomics Limited | 88 |
4 |
| Curadev Pharma Pvt Ltd. | 21 |
4 |
| Kancera AB | 34 |
4 |
| Memorial Sloan-Kettering Cancer Center | 1929 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 870 |
4 |
| UCB Pharma GmbH | 88 |
4 |
| Bristol-myers Squibb Company | 4898 |
3 |
| FUJIFILM Corporation | 29367 |
3 |
| Abbvie Inc. | 1800 |
3 |
| Other owners | 116 |